Zacks Small Cap Research on MSN20m
REVB Gets FDA Go AheadREVB READ THE FULL REVB RESEARCH REPORT Revelation Biosciences (NASDAQ:REVB) announced that the FDA has accepted the company’s IND application for Gemini. This announcement allows the Company to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback